Drug application
LIDOCAINE (LIDOCAINE)
Drugs@FDA ANDA 209190 · IBSA
Key facts
| Drug name | LIDOCAINE |
|---|---|
| Active ingredients | LIDOCAINE |
| Application type | ANDA |
| Application number | 209190 |
| Company | IBSA |
| Dosage forms | PATCH, TOPICAL |
| Strength | 5% |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Apr 30, 2020 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: